4 Overstated
Vitamin D, vitamin K2, and magnesium help alleviate vertigo by managing calcium crystal accumulation in the inner ear.
"vitamin D and vitamin K2 and magnesium do help with that because of the calcium crystals that build up." (said at 0:28:47)
Benign paroxysmal positional vertigo (BPPV) is caused by dislodged calcium carbonate crystals (otoconia) entering the semicircular canals of the inner ear. There is evidence that vitamin D deficiency is associated with BPPV and that vitamin D supplementation may reduce BPPV recurrence in patients with deficiency. However, there is no clinical trial evidence demonstrating that vitamin K2 or magnesium supplementation prevents, treats, or alleviates vertigo or clears calcium crystal accumulation in the inner ear. While magnesium is a trace structural component of human otoconia crystals, claims that supplementing vitamin K2 and magnesium manages otoconial vertigo represent an extrapolation beyond clinical evidence.
Hepatic hemangiomas are estrogen-sensitive benign vascular clusters that shrink in postmenopausal women.
"That's a cluster of blood vessels in the liver. It's benign; it won't turn into a tumor. Sometimes it's related to estrogen, and so this is why in postmenopausal females it shrinks with age." (said at 0:31:38)
Hepatic hemangiomas are benign vascular lesions of the liver whose growth is influenced by female sex hormones, and exogenous estrogen therapy can stimulate their enlargement. However, claiming that hemangiomas routinely shrink with age in postmenopausal women overstates the evidence. Prospective natural history studies show that most hepatic hemangiomas remain stable in size over long-term follow-up, and while spontaneous regression following menopause or cessation of hormone therapy can occur, it is documented in published literature as a rare phenomenon rather than a predictable or typical outcome.
A clinical study showed that heavy resistance weight training reversed osteopenia and osteoporosis in women and salvaged muscle.
"Now you might you might think that there was an interesting study related to women that were they had osteopenia and osteoporosis and you would think that you would have to be very very fragile and careful and everything and and you have to do this safely, but they put these women on um heavier weights and and had done it on a gradient correctly and not only did they get rid of their osteopenia and osteoporosis, but they salvaged their muscles." (said at 0:52:30)
The speaker appears to be referring to the LIFTMOR trial (and related work), a randomized controlled trial investigating supervised high-intensity resistance and impact training (HiRIT; >85% 1-repetition maximum) in postmenopausal women with low to very low bone mass (osteopenia and osteoporosis). The trial demonstrated that progressive heavy resistance training is safe and significantly improves lumbar spine bone mineral density (+2.9%), femoral neck bone mineral density (+0.3%), cortical thickness, and muscle strength/functional performance compared to low-intensity controls who lost bone density. However, claiming that the intervention 'got rid of' or completely reversed osteopenia and osteoporosis overstates the magnitude of the effect, as a modest percentage increase in bone mineral density improves bone strength and mitigates age-related bone loss but does not eliminate or fully cure established osteopenia or osteoporosis.
- partial: Heavy resistance training is safe and improves bone, function, and stature in postmenopaus… (Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2015) · cited 112x in the literature
"HiPRT and impact loading (n = 12) improved height (0.4 ± 0.2 cm vs -0.3 ± 0.1 cm, p = 0.003), femoral neck bone mineral density (0.3 ± 0.5 % vs -2.5 ± 0.8 %, p = 0.016), lumbar spine bone mineral density (1.6 ± 0.9 % vs -1.7 ± 0.6 %, p = 0.005), and functional performance (p < 0.05), compared to controls (n = 16)." (abstract, results, passage verified)
pubmedfull study (doi) - partial: High-Intensity Resistance and Impact Training Improves Bone Mineral Density and Physical F… (Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2018) · cited 445x in the literature
"HiRIT (n = 49) effects were superior to CON (n = 52) for lumbar spine (LS) BMD (2.9 ± 2.8% versus -1.2 ± 2.8%, p < 0.001), femoral neck (FN) BMD (0.3 ± 2.6% versus -1.9 ± 2.6%, p = 0.004), FN cortical thickness (13.6 ± 16.6% versus 6.3 ± 16.6%, p = 0.014), height (0.2 ± 0.5 cm versus -0.2 ± 0.5 cm, p = 0.004), and all functional performance measures (p < 0.001)." (abstract, results, passage verified)
pubmedfull study (doi)
Magnesium enhances sleep quality by supporting GABA neurotransmission in the brain.
"Well, magnesium will help not just sleep, but it will help with the quality of sleep, GABA in your brain. I think it can greatly assist in all aspects of sleep problems." (said at 0:43:43)
Preclinical and mechanistic literature indicates that magnesium acts as an NMDA receptor antagonist and positive modulator of GABAergic neurotransmission, which plays an important role in central nervous system inhibition and sleep architecture. However, clinical evidence demonstrating that magnesium supplementation reliably improves sleep quality or resolves overall sleep problems remains limited and inconsistent. Systematic reviews and meta-analyses of randomized controlled trials (such as those by Mah & Pitre, 2021, and Arab et al., 2023) note modest improvements in subjective measures such as sleep onset latency in specific populations (primarily older adults with insomnia), but report that available trials are small, have moderate-to-high risk of bias, and provide low to very low certainty of overall clinical benefit.
- context: The effect of magnesium supplementation on primary insomnia in elderly: A double-blind pla… (Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences 2012) · cited 114x in the literature
"The natural N-methyl-D-aspartic acid (NMDA) antagonist and GABA agonist, Mg(2+), seems to play a key role in the regulation of sleep." (abstract, introduction, passage verified)
pubmed - partial: Oral magnesium supplementation for insomnia in older adults: a Systematic Review & Meta-An… (BMC complementary medicine and therapies 2021) · cited 52x in the literature
"Three randomized control trials (RCT) were identified comparing oral magnesium to placebo in 151 older adults in three countries. Pooled analysis showed that post-intervention sleep onset latency time was 17.36 min less after magnesium supplementation compared to placebo (95% CI - 27.27 to - 7.44, p = 0.0006)... All trials were at moderate-to-high risk of bias and outcomes were supported by low to very low quality of evidence." (abstract, results, passage verified)
pubmedfull study (doi) - partial: The Role of Magnesium in Sleep Health: a Systematic Review of Available Literature. (Biological trace element research 2023) · cited 74x in the literature
"This systematic review revealed an association between magnesium status and sleep quality (daytime falling asleep, sleepiness, snoring, and sleep duration) according to the observational studies, while the randomized clinical trials showed an uncertain association between magnesium supplementation and sleep disorders." (abstract, results, passage verified)
pubmedfull study (doi)
7 Needs context
Berberine is clinically equivalent to metformin in lowering HbA1c and reducing postprandial blood glucose in pre-diabetics and diabetics.
"it does lower your A1C. It does help reduce blood sugars after eating. Uh very similar results." (said at 0:13:40)
Small randomized clinical trials have found that berberine significantly lowers HbA1c, fasting plasma glucose, and postprandial blood glucose in patients with type 2 diabetes, producing reductions comparable in magnitude to metformin monotherapy (such as berberine 500 mg three times daily). However, systematic reviews emphasize that the evidence base consists of small trials with low methodological quality, limited sample sizes, and unclear risk of bias. While preliminary data demonstrate comparable glycemic effects in short-term pilot studies, larger, high-quality randomized controlled trials are needed to firmly establish clinical equivalence.
- supports: Efficacy of berberine in patients with type 2 diabetes mellitus. (Metabolism: clinical and experimental 2008) · cited 785x in the literature
"In study A, 36 adults with newly diagnosed type 2 diabetes mellitus were randomly assigned to treatment with berberine or metformin (0.5 g 3 times a day) in a 3-month trial. The hypoglycemic effect of berberine was similar to that of metformin. Significant decreases in hemoglobin A1c (from 9.5%+/-0.5% to 7.5%+/-0.4%, P<.01), fasting blood glucose (from 10.6+/-0.9 mmol/L to 6.9+/-0.5 mmol/L, P<.01), postprandial blood glucose (from 19.8+/-1.7 to 11.1+/-0.9 mmol/L, P<.01), and plasma triglycerides (from 1.13+/-0.13 to 0.89+/-0.03 mmol/L, P<.05) were observed in the berberine group." (abstract, results, passage verified)
pubmedfull study (doi) - context: Berberine in the treatment of type 2 diabetes mellitus: a systemic review and meta-analysi… (Evidence-based complementary and alternative medicine : eCAM 2012) · cited 222x in the literature
"Compared with oral hypoglycaemics including metformin, glipizide, or rosiglitazone, berberine did not demonstrate a significantly better glycaemic control but showed a mild antidyslipidemic effect... However, the evidence of berberine for treating T2DM should be carefully interpreted due to the low methodological quality, small sample size, limited number of trials, and unidentified risks of bias." (abstract, results and conclusions)
pubmedfull study (doi)
Consuming refined carbohydrates, alcohol, and tea depletes bodily stores of vitamin B1.
"And when you consume more refined carbs, you you use up your B1. When you drink alcohol, you use up your B1. When you consume more tea, you use up a lot of your stored B1." (said at 0:16:54)
The statement contains a mixture of established metabolic principles and overstated mechanisms across the three substances. Alcohol intake is well-established to induce thiamine (vitamin B1) deficiency by impairing intestinal absorption, reducing hepatic storage, and interfering with its phosphorylation and utilization. Diets high in refined carbohydrates increase metabolic demand for thiamine, as thiamine pyrophosphate serves as an essential cofactor for key glucose-utilizing enzymes (such as pyruvate dehydrogenase, transketolase, and alpha-ketoglutarate dehydrogenase), which can precipitate deficiency if intake does not match demand. However, tea does not deplete or 'use up' endogenous bodily stores of thiamine; rather, tannins and polyphenolic compounds in tea act as anti-thiamine factors in the digestive tract by binding to or modifying dietary thiamine, thereby inhibiting its intestinal absorption when consumed concurrently with meals.
Dietary glutamine helps heal and repair the intestinal lining.
"carnivore which actually are very very successful at kind of healing the gut because it's high in glutamine which actually can help heal the gut." (said at 0:12:19)
Glutamine is the primary metabolic fuel for enterocytes and plays a well-established physiological role in maintaining intestinal epithelial integrity and tight junction regulation. In clinical trials, oral glutamine supplementation has demonstrated improvements in intestinal permeability in specific conditions, such as post-infectious irritable bowel syndrome with baseline hyperpermeability, and meta-analyses suggest reductions in permeability at higher supplemental doses (>30 g/day). However, systematic reviews in broader clinical populations, such as inflammatory bowel disease, have shown mixed or null therapeutic benefits on mucosal healing, and there is no clinical evidence demonstrating that dietary glutamine from specific regimens (such as a carnivore diet) heals the gut.
- supports: Glutamine and the regulation of intestinal permeability: from bench to bedside. (Current opinion in clinical nutrition and metabolic care 2017) · cited 80x in the literature
"Glutamine is a major nutrient to maintain intestinal barrier function in animals and humans. Depletion of glutamine results in villus atrophy, decreased expression of tight junction proteins and increased intestinal permeability. Moreover, glutamine supplementation can improve gut barrier function in several experimental conditions of injury and in some clinical situations." (abstract, conclusions, passage verified)
pubmedfull study (doi) - supports: Randomised placebo-controlled trial of dietary glutamine supplements for postinfectious ir… (Gut 2019) · cited 188x in the literature
"In patients with IBS-D with intestinal hyperpermeability following an enteric infection, oral dietary glutamine supplements dramatically and safely reduced all major IBS-related endpoints." (abstract, conclusions, passage verified)
pubmedfull study (doi) - partial: Effects of glutamine supplementation on inflammatory bowel disease: A systematic review of… (Clinical nutrition ESPEN 2021) · cited 40x in the literature
"The findings obtained through this systematic review indicate that glutamine supplementation has no effect on disease course, anthropometric measurements, intestinal permeability and morphology, disease activity, intestinal symptoms, biochemical parameters, oxidative stress and inflammation markers in patients with IBD" (abstract, conclusions, passage verified)
pubmedfull study (doi) - partial: A systematic review and meta-analysis of clinical trials on the effects of glutamine suppl… (Amino acids 2024) · cited 19x in the literature
"Overall, glutamine supplementation did not significantly affect intestinal permeability (WMD: -0.00, 95% CI -0.04, 0.03). Subgroup analysis showed a significant reduction in intestinal permeability with doses over 30g/day (WMD: -0.01, 95% CI -0.10, -0.08)." (abstract, results, passage verified)
pubmedfull study (doi)
Insulin resistance is mechanistically linked to sleep apnea by promoting fat deposition in the pharynx and upper airway.
"Sleep apnea has been linked to something called insulin resistance... Well, the insulin starts making more and more and more and more and more with insulin resistance and then uh one of the effects is sleep apnea. So you just you it starts creating fat in the back of the throat and you you're breathing, you snore, you have you can't get air" (said at 0:25:03)
Obstructive sleep apnea (OSA), obesity, and insulin resistance are closely linked, but the speaker simplifies and partially reverses the primary causal mechanisms. Anatomical upper airway narrowing—caused by fatty tissue deposition in the pharyngeal walls and tongue—is primarily driven by overall adiposity and obesity rather than being a direct isolated consequence of hyperinsulinemia. Furthermore, evidence indicates a strong bidirectional relationship in which sleep apnea and intermittent hypoxia exacerbate insulin resistance and metabolic dysfunction, rather than insulin resistance acting solely as the upstream cause of throat fat accumulation.
- context: Abdominal fat and sleep apnea: the chicken or the egg? (Diabetes care 2008) · cited 40x in the literature
"There are several mechanisms responsible for the increased risk of OSA with obesity. These include reduced pharyngeal lumen size due to fatty tissue within the airway or in its lateral walls, decreased upper airway muscle protective force due to fatty deposits in the muscle, and reduced upper airway size secondary to mass effect of the large abdomen on the chest wall and tracheal traction." (abstract, results, passage verified)
pubmedfull study (doi) - context: Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome. (Journal of the American College of Cardiology 2013) · cited 881x in the literature
"Moreover, findings from animal models and patients with OSA show that intermittent hypoxia exacerbates the metabolic dysfunction of obesity, augmenting insulin resistance and nonalcoholic fatty liver disease." (abstract, results, passage verified)
pubmedfull study (doi) - context: Sleep Apnea, Obesity, and Disturbed Glucose Homeostasis: Epidemiologic Evidence, Biologic … (Current obesity reports 2020) · cited 94x in the literature
"The mechanisms hypothesized to be involved in this complex interplay are the following: (1) "direct weight-dependent" mechanisms, according to which fat excess compromises respiratory mechanics, and (2) "indirect weight-dependent" mechanisms such as hyperglycemia, insulin resistance and secondary hyperinsulinemia, leptin resistance and other hormonal dysregulations frequently found in subjects with obesity, type 2 diabetes, and/or sleep disorders." (abstract, results, passage verified)
pubmedfull study (doi)
Uric acid levels rise during the initial adaptation phase of entering ketosis.
"So when you go on keto, it's possible that your uric acid will go up initially in the first phase, but then it goes down. But it's part of the adaptation process." (said at 0:44:44)
The speaker's statement that uric acid may rise transiently during initial ketogenic adaptation before returning to baseline is biologically plausible and documented during acute ketosis (where circulating ketone bodies like beta-hydroxybutyrate compete with uric acid for renal tubular secretion). However, systematic reviews and meta-analyses of clinical trials evaluating ketogenic diets over several weeks find that overall serum uric acid levels do not show sustained or significant net increases compared to baseline across study endpoints.
Gout is caused by fructose, and the theory that dietary protein causes gout has been debunked.
"But usually gout comes from the fructose. And in gout, I've seen so many people with gout go on low-carb and get rid of their gout. So, this whole theory that gout comes from eating protein has been debunked long ago." (said at 0:45:00)
The claim contains accurate elements but requires important qualification. Fructose and sugar-sweetened beverage consumption are indeed established risk factors associated with an increased risk of incident gout (PMID 18244959, PMID 21068145); however, fructose is only one contributing factor among major causes such as genetic variants, impaired renal urate clearance, alcohol consumption, and obesity. Regarding protein, prospective cohort research confirms that total dietary protein intake is not associated with an increased risk of gout (PMID 15014182). However, stating that protein's link to gout has been entirely debunked is incomplete: specific purine-dense animal proteins, namely red meat and seafood, remain well-documented risk factors for hyperuricemia and incident gout (PMID 15014182).
- partial: Purine-rich foods, dairy and protein intake, and the risk of gout in men. (The New England journal of medicine 2004) · cited 1191x in the literature
"Higher levels of meat and seafood consumption are associated with an increased risk of gout, whereas a higher level of consumption of dairy products is associated with a decreased risk." (abstract, conclusions, passage verified)
pubmedfull study (doi) - supports: Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study. (BMJ (Clinical research ed.) 2008) · cited 583x in the literature
"Prospective data suggest that consumption of sugar sweetened soft drinks and fructose is strongly associated with an increased risk of gout in men." (abstract, conclusions, passage verified)
pubmedfull study (doi) - context: Fructose-rich beverages and risk of gout in women. (JAMA 2010) · cited 316x in the literature
"Among this cohort of women, consumption of fructose-rich beverages is associated with an increased risk of incident gout, although the contribution of these beverages to the risk of gout in the population is likely modest given the low incidence rate among women." (abstract, conclusions, passage verified)
pubmedfull study (doi)
There are at least 31 distinct diseases causally or pathophysiologically connected to insulin resistance.
"If it works on insulin resistance, then it obviously is going to work on everything connected to that, and there's at least 31 different diseases connected with insulin resistance." (said at 0:35:20)
Extensive epidemiological and mechanistic research establishes that insulin resistance is pathophysiologically linked to a broad spectrum of chronic diseases spanning multiple organ systems—including type 2 diabetes, cardiovascular disease, metabolic dysfunction-associated steatotic liver disease (MASLD), polycystic ovary syndrome (PCOS), Alzheimer's disease, and multiple malignancies. However, the specific figure of 'at least 31 distinct diseases' represents an informal or popular categorization rather than a standardized epidemiological or clinical classification. Furthermore, while improving insulin sensitivity can ameliorate many metabolic risk factors, asserting that treating insulin resistance will 'obviously work on everything connected to that' overstates the evidence, as these diseases are multifactorial conditions with independent genetic, environmental, and non-metabolic drivers.
- context: A Comprehensive Review of Pathophysiological Link Between Non-alcoholic Fatty Liver Diseas… (Cureus 2024) · cited 11x in the literature
"The review indicates that IR contributes to hepatic lipid accumulation through increased lipolysis, elevated free fatty acid flux, and impaired fatty acid oxidation, while MetS exacerbates the condition by promoting visceral adiposity, chronic inflammation, and impaired lipid metabolism." (abstract, results, passage verified)
pubmedfull study (doi) - context: Metabolic Syndrome in Focus: Emerging Causes, New Diagnostic Approaches and Criteria, and … (Cureus 2026) · cited 3x in the literature
"Metabolic syndrome (MetS) is a complex cluster of metabolic abnormalities, including central obesity, hypertension, dyslipidemia, insulin resistance, and impaired glucose metabolism. Growing evidence indicates that MetS is not only a major risk factor for cardiovascular disease but is also strongly associated with the development and progression of various malignancies." (abstract, results, passage verified)
pubmedfull study (doi)
19 Supported by research
In certain autoimmune disease protocols, monitored vitamin D blood levels are pushed up to 200 ng/mL.
"there is data even if you have certain types of autoimmune problems where they'll push it up to 200, you know, but but here's the thing, they're monitoring it, right?" (said at 0:05:33)
High-dose vitamin D protocols investigated or utilized in autoimmune disorders (such as multiple sclerosis), including dose-escalation trials and clinical protocols like the Coimbra Protocol, administer daily doses ranging from 30,000 to over 40,000 IU/day (or up to 1,000 IU/kg). In dose-escalation research in multiple sclerosis (Kimball et al., 2010), serum 25(OH)D reached a mean peak of 413 nmol/L (~165 ng/mL, with individual levels exceeding 200 ng/mL / 500 nmol/L). These regimens require rigorous clinical and biochemical monitoring—including serum and urinary calcium, renal function (creatinine, cystatin C), hydration, and parathyroid hormone (PTH) suppression—to mitigate the risks of hypercalcemia and renal dysfunction.
- supports: A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis. (Neurology 2010) · cited 362x in the literature
"Treatment patients received escalating vitamin D doses up to 40,000 IU/day over 28 weeks to raise serum 25-hydroxyvitamin D [25(OH)D] rapidly and assess tolerability, followed by 10,000 IU/day (12 weeks), and further downtitrated to 0 IU/day... Despite a mean peak 25(OH)D of 413 nmol/L, no significant adverse events occurred." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Vitamin D Resistance as a Possible Cause of Autoimmune Diseases: A Hypothesis Confirmed by… (Frontiers in immunology 2021) · cited 64x in the literature
"We particularly focus on its clinical confirmation from our experience of treating multiple sclerosis patients with the so-called Coimbra protocol, in which daily doses up to 1000 I.U. vitamin D 3 per kg body weight can be administered safely. Parathyroid hormone levels in serum thereby provide the key information for finding the right dose." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Safety Data in Patients with Autoimmune Diseases during Treatment with High Doses of Vitam… (Nutrients 2022) · cited 26x in the literature
"We report for the first time for a broad spectrum of autoimmune diseases in 319 patients (mean age (±SD) 43.3 ± 14.6 years, 65.5% female, 34.5% male) safety data for high doses of orally applied vitamin D3 (treatment period: up to 3.5 years) accompanied by a strict low-calcium diet and regular daily fluid intake of at least 2.5 L. Mean vitamin D3 dose was 35,291 ± 21,791 IU per day... Our data show the reliable safety of the CP in autoimmune patients under appropriate supervision by experienced physicians." (abstract, results and conclusions, passage verified)
pubmedfull study (doi)
Menopause accelerates muscle loss, leading to sarcopenia and anabolic resistance.
"one of the problems with menopause is that you start losing um muscle mass pretty quick. And so, uh, sometimes there's this condition that develops, um, that's you're you're eating right, you're exercising, and there's just like there's resistance, and so then you into the muscle. So, then you get atrophy and, uh, it's called sarcopenia where you're losing muscle mass." (said at 0:07:37)
Published observational studies and physiological reviews demonstrate that the menopausal transition is associated with accelerated loss of lean muscle mass and increased prevalence of sarcopenia. Furthermore, postmenopausal status is associated with blunted muscle protein synthesis responses to anabolic stimuli such as dietary protein and resistance exercise, a phenomenon known as anabolic resistance.
- supports: Anabolic resistance: the effects of aging, sexual dimorphism, and immobilization on human … (Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme 2009) · cited 133x in the literature
"postmenopausal women have a greater anabolic resistance than older men." (abstract, passage verified)
pubmedfull study (doi) - supports: Menopause and sarcopenia: A potential role for sex hormones. (Maturitas 2011) · cited 402x in the literature
"Menopause is associated with a decline in estrogen levels, which could lead to an increase in visceral adiposity as well as a decrease in bone density, muscle mass and muscle strength. This decline in muscle mass, known as sarcopenia, is frequently observed in postmenopausal women." (abstract, passage verified)
pubmedfull study (doi) - supports: Menopause, Female Sex Hormones, Skeletal Muscle Mass and Muscle Protein Turnover in Humans… (Journal of cachexia, sarcopenia and muscle 2026) · cited 7x in the literature
"Longitudinal (n = 4/5) and cross-sectional (n = 7/11) studies demonstrate a reduction in lean or muscle mass across the menopausal transition with -2.5% and -5.7% reductions in perimenopausal and postmenopausal women, respectively, compared to premenopausal women." (abstract, passage verified)
pubmedfull study (doi)
Following discontinuation of GLP-1 medications, the majority of patients regain most of the lost weight without regaining lost muscle mass.
"So when you come off of it, uh the data is like the majority of people will gain back most of the weight. um but not the muscle that they lost. So there's significant muscle loss." (said at 0:09:42)
Evidence from randomized trial extensions and clinical reviews confirms both aspects of the claim. In the 1-year off-treatment extension of the STEP 1 trial (Wilding et al., 2022), participants who discontinued once-weekly subcutaneous semaglutide regained approximately two-thirds (11.6 of the 17.3 percentage points lost) of their prior weight loss, along with a reversion of cardiometabolic improvements toward baseline. Furthermore, clinical reviews highlight that while roughly 25% to 40% of initial weight lost on GLP-1 receptor agonists is lean mass, subsequent weight regain consists predominantly of adipose (fat) tissue rather than skeletal muscle unless paired with structured resistance exercise, compounding lean tissue deficits and worsening overall body composition.
- supports: Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 tria… (Diabetes, obesity & metabolism 2022) · cited 1023x in the literature
"One year after withdrawal of once-weekly subcutaneous semaglutide 2.4 mg and lifestyle intervention, participants regained two-thirds of their prior weight loss, with similar changes in cardiometabolic variables." (abstract, conclusions, passage verified)
pubmedfull study (doi) - supports: New drugs for weight loss: Why change in body composition matters and why nutrition and ex… (Canadian family physician Medecin de famille canadien 2025)
"There is observational evidence that weight cycling may be harmful in that weight regain can be composed primarily of fat, multiple cycles of which may actually increase obesity in individuals." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Metabolic rebound and weight cycling following incretin mimetic drug withdrawal: a cause f… (Current opinion in clinical nutrition and metabolic care 2026)
"Cessation of IMD therapy leads to a rapid and near-complete reversal of weight loss and cardiometabolic improvement within one year and early IMD discontinuation is associated with increased cardiometabolic risk. Concerningly, up to 40% of the weight lost on these therapies is attributed to lean mass loss. Weight cycling compounds these effects and may worsen body composition and metabolic profiles beyond baseline." (abstract, results, passage verified)
pubmedfull study (doi)
Zinc carnosine promotes the healing of the gastrointestinal gut lining.
"There's some data that shows that zinc carnosine can help help a gut heal." (said at 0:12:19)
Zinc-L-carnosine (also known as polaprezinc) is an approved pharmaceutical agent in Japan and a widely used dietary supplement with documented mucosal cytoprotective, anti-inflammatory, and healing-promoting properties in the gastrointestinal tract. Clinical trials and systematic reviews demonstrate that zinc carnosine promotes gastric and intestinal mucosal healing, accelerates the resolution of gastric ulcers, protects against NSAID-induced small intestinal injury, and helps restore gut epithelial barrier integrity.
- supports: A Review of Zinc-L-Carnosine and Its Positive Effects on Oral Mucositis, Taste Disorders, … (Nutrients 2020) · cited 56x in the literature
"There are several studies that support ZnC's benefits in restoring the gastric lining, healing other parts of the gastrointestinal (GI) tract, improving taste disorders, improving GI disorders, and enhancing skin and liver." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Comparison of the Efficacy of Polaprezinc Plus Proton Pump Inhibitor and Rebamipide Plus P… (Journal of clinical gastroenterology 2021) · cited 13x in the literature
"Polaprezinc is effective for promoting ulcer healing and helps enhance the quality of ulcer healing." (abstract, background, passage verified)
pubmedfull study (doi) - supports: The role of Zinc L-Carnosine in the prevention and treatment of gastrointestinal mucosal d… (Clinics and research in hepatology and gastroenterology 2022) · cited 22x in the literature
"It has been shown to promote repair of mucosal injury in human studies and has been widely used for the treatment of peptic ulcers, chemoradiotherapy-induced oral mucositis and esophagitis. More recently, the therapeutic applications of Zinc L-carnosine have been extended to the prevention and cure of various types of intestinal damage, including ulcerative colitis, iatrogenic ulcers after operative endoscopy, hemorrhoidal disease and impaired intestinal permeability." (abstract, results, passage verified)
pubmedfull study (doi)
Berberine is more effective than metformin at reducing blood triglycerides and LDL cholesterol.
"berberine actually is even stronger in reducing triglycerides and LDL." (said at 0:13:40)
Head-to-head randomized clinical trials comparing berberine to metformin (such as in patients with polycystic ovary syndrome or type 2 diabetes) have found that while both agents exert comparable effects on glucose regulation, berberine produces statistically greater reductions in total cholesterol, LDL cholesterol, and triglycerides than metformin.
- supports: A clinical study on the short-term effect of berberine in comparison to metformin on the m… (European journal of endocrinology 2012) · cited 160x in the literature
"Treatment with BBR in comparison to MET showed decrease in waist circumference and waist-to-hip ratio (WHR; P<0.01), total cholesterol (TC), triglycerides (TG), and low-density lipoprotein cholesterol (LDLC; P<0.05) as well as increase in high-density lipoprotein cholesterol (HDLC) and sex hormone-binding globulin (SHBG; P<0.05)." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Study on the Effect of Berberine, Myoinositol, and Metformin in Women with Polycystic Ovar… (Cureus 2022) · cited 16x in the literature
"Between the three groups, berberine showed greater differences in clinical, hormonal, and lipid parameters compared to metformin and myoinositol, while myoinositol showed greater improvement in carbohydrate metabolic parameters." (abstract, results, passage verified)
pubmedfull study (doi)
Pork contains higher concentrations of vitamin B1 (thiamine) than other meats.
"pork, believe it or not, high quality pork has more B1 than other meats." (said at 0:16:54)
Nutritional analyses and dietary intake studies show that pork is an exceptionally rich source of vitamin B1 (thiamine) compared to other common meats such as beef and poultry. Population-level dietary analyses indicate that pork consumption contributes substantially to daily thiamine intake and nutritional adequacy.
- supports: Association of Pork (All Pork, Fresh Pork and Processed Pork) Consumption with Nutrient In… (Nutrients 2023) · cited 22x in the literature
"Among consumers of AP, FP and PP, the intakes of copper, potassium, selenium, sodium, zinc, thiamine, niacin, vitamin B 6 and choline were higher ( p < 0.05) and a higher ( p < 0.05) proportion met nutrient recommendations for copper, potassium, zinc, thiamin and choline compared to non-consumers." (abstract, results, passage verified)
pubmedfull study (doi)
Humans are born with roughly one million nephrons per kidney and destroyed nephrons cannot regenerate.
"you are um born with a million um kidney cells, you know, per um kidney and nephrons and once they go, they're gone. You can't can't get them back." (said at 0:18:29)
Human nephrogenesis is complete by approximately 36 weeks of gestation, when the nephron progenitor cell pool is exhausted. Humans are born with an average nephron endowment of approximately 900,000 to 1,000,000 per kidney (with substantial individual variation ranging from roughly 200,000 to over 2 million). Because developmental nephrogenesis ceases before or around birth, no new nephrons can be formed postnatally, meaning lost or destroyed nephrons cannot regenerate.
The primary fuel of nephrons in the renal cortex is fatty acids and ketones rather than glucose.
"The outer part where all the nephrons are, its primary fuel is fat. It doesn't use glucose. Fat and ketones." (said at 0:25:44)
The host's statement is largely supported by established renal physiology, though slightly overstated in claiming that the renal cortex "doesn't use glucose" at all. In the healthy kidney, the cortex (composed largely of proximal tubules, which carry out massive active transport) relies predominantly on mitochondrial fatty acid oxidation and ketone bodies rather than glycolysis/glucose oxidation to meet its high ATP demands. Proximal tubular epithelial cells have low glycolytic capacity and primarily metabolize lipids and ketones under normal physiological conditions, although other cortical nephron segments and specific pathological states (such as acute kidney injury) can engage glucose metabolism.
Kidney nephrons perform gluconeogenesis to synthesize glucose for the body.
"Your nephron makes glucose just like the liver, but it doesn't use it as fuel, but it makes it to help the liver." (said at 0:25:44)
Renal proximal tubule cells in the nephron are well-established sites of gluconeogenesis. The kidney possesses the necessary gluconeogenic enzymes and synthesizes glucose from precursors such as lactate, glutamine, and glycerol, releasing it into the systemic circulation to contribute significantly to whole-body glucose homeostasis alongside hepatic glucose production.
A substantial portion of active vitamin D is synthesized by the kidneys.
"tremendous amount of your vitamin D is activated by the kidney." (said at 0:27:15)
The kidneys are the primary physiological site for activating vitamin D into its circulating endocrine form, 1,25-dihydroxyvitamin D (calcitriol). In the standard metabolic pathway, vitamin D precursors are first 25-hydroxylated in the liver to form 25-hydroxyvitamin D, and the final rate-limiting 1-alpha-hydroxylation step occurs in the renal proximal tubules via the enzyme CYP27B1 (1-alpha-hydroxylase), which is tightly regulated by parathyroid hormone, fibroblast growth factor 23, and calcitriol itself to maintain systemic calcium and phosphate homeostasis.
- supports: Mechanistic homeostasis of vitamin D metabolism in the kidney through reciprocal modulatio… (The Journal of steroid biochemistry and molecular biology 2020) · cited 93x in the literature
"Collectively, the hormone-mediated enhancer regulation of both Cyp27b1 and Cyp24a1 in the kidney is responsible for the circulating levels of 1,25(OH) 2 D 3 in the blood which in turn primarily affects calcium and phosphate regulation." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Regulation of 1 and 24 hydroxylation of vitamin D metabolites in the proximal tubule. (Experimental biology and medicine (Maywood, N.J.) 2022) · cited 44x in the literature
"Calcitriol synthesis is a multistep process. A precursor is first made via skin exposure to UV, it is then 25-hydroxylated in the liver to form 25-hydroxyitamin D. The next hydroxylation step occurs in the renal proximal tubule via the 1-αhydroxylase enzyme (encoded by CYP27B1) thereby generating 1,25-dihydroxyvitamin D, that is, calcitriol." (abstract, results, passage verified)
pubmedfull study (doi)
Zinc helps reduce yeast and fungus, and copper is an antifungal agent also used in agriculture.
"Now, it is true that zinc does help reduce yeast and fungus, but also when you're taking zinc without copper—copper is a known antifungal that you even use in agriculture." (said at 0:31:11)
Both components of the claim are well supported by scientific literature. Copper compounds (such as copper sulfate and Bordeaux mixture) have a long-established history as broad-spectrum antifungal agents and fungicides widely used in agriculture to protect crops and vineyards against fungal pathogens. Zinc and zinc-based formulations also possess well-documented antifungal properties against yeasts and pathogenic fungi, operating through both direct biochemical toxicity and host nutritional immunity pathways.
- supports: Harnessing Metal Homeostasis Offers Novel and Promising Targets Against Candida albicans. (Current drug discovery technologies 2020) · cited 7x in the literature
"Micronutrient availability during C. albicans infection is regarded as a critical factor that influences the progression and magnitude of the disease. Intracellular pathogens colonize a variety of anatomical locations that are likely to be scarce in micronutrients, as a defense strategy adopted by the host, known as nutritional immunity." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Adverse effects of the Bordeaux mixture copper-based fungicide on the non-target vineyard … (Pest management science 2024) · cited 17x in the literature
"Bordeaux mixture is a copper-based fungicide commonly used in vineyards to prevent fungal and bacterial infections in grapevines." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Synthesis, characterization, and antifungal activity of chitosan-copper nanocomposites aga… (Frontiers in fungal biology 2026) · cited 2x in the literature
"These findings demonstrate that CHT-Cu NPs possess broad-spectrum antifungal activity and superior efficacy compared to conventional fungicides, highlighting their potential as eco-compatible nanobiopesticides for sustainable management of fungal diseases in crop plants." (abstract, results, passage verified)
pubmedfull study (doi)
Cinnamon decreases and improves insulin resistance.
"But cinnamon has been shown to decrease and help insulin resistance." (said at 0:35:10)
Multiple systematic reviews and meta-analyses of randomized controlled trials demonstrate that cinnamon supplementation significantly reduces homeostatic model assessment for insulin resistance (HOMA-IR), fasting blood glucose, and related glycemic indices in individuals with type 2 diabetes, pre-diabetes, and polycystic ovary syndrome (PCOS).
- supports: The effect of cinnamon supplementation on glycemic control in patients with type 2 diabete… (Diabetology & metabolic syndrome 2023) · cited 34x in the literature
"Cinnamon supplementation was effective in reducing serum FPG (WMD: -10.93 mg/dL; 95%CI: -16.22, -5.65; SMD: -0.86; 95%CI: -1.19, -0.52), insulin (WMD: -2.01 IU/mL; 95%CI: -3.96, -0.07; SMD: -0.61; 95%CI: -0.93, -0.30), HOMA-IR levels (WMD: -0.61; 95%CI: -0.91, -0.31; SMD: -0.78; 95%CI: -1.26, -0.30), and HbA1c (WMD: -0.10%; 95%CI: -0.17, -0.03)." (abstract, results, passage verified)
pubmedfull study (doi) - supports: The effect of cinnamon supplementation on glycemic control in patients with type 2 diabete… (Phytotherapy research : PTR 2024) · cited 43x in the literature
"Findings from 24 RCTs revealed that cinnamon supplementation had a statistically significant reduction in fasting blood sugar (SMD: -1.32; 95% CI: -1.77, -0.87, p < 0.001), Homeostatic Model Assessment for Insulin Resistance (SMD: -1.32; 95% CI: -1.77, -0.87, p < 0.001), and hemoglobin A1C (SMD: -0.67; 95% CI: -1.18, -0.15, p = 0.011) compared with the control group in patients with T2DM." (abstract, results, passage verified)
pubmedfull study (doi)
Berberine drops blood sugar and HbA1c in human randomized controlled trials and is similar in function to metformin.
"But berberine is very similar to metformin, the drug, which is actually modeled after a natural remedy too, but it can definitely drop your blood sugars and A1C and help a lot of different things. I was amazed at the amount of research berberine has—credible human randomized control trials." (said at 0:35:15)
Multiple systematic reviews and meta-analyses of randomized controlled trials (RCTs) confirm that berberine supplementation significantly lowers fasting blood glucose, postprandial glucose, and HbA1c levels in adults with metabolic disorders and type 2 diabetes. Furthermore, research comparing berberine and metformin indicates that both compounds share similar metabolic mechanisms (such as AMPK pathway activation and gut microbiome regulation) and yield comparable therapeutic benefits in metabolic health.
- supports: The Effect of Berberine on Metabolic Profiles in Type 2 Diabetic Patients: A Systematic Re… (Oxidative medicine and cellular longevity 2021) · cited 108x in the literature
"Analysis of berberine applied alone or with standard diabetic therapies versus the control group revealed significant reductions in HbA1c (MD = -0.73; 95% CI (-0.97, -0.51)), FPG (MD = -0.86, 95% CI (-1.10, -0.62)), and 2hPG (MD = -1.26, 95% CI (-1.64, -0.89))." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Berberine is a potential alternative for metformin with good regulatory effect on lipids i… (Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2023) · cited 30x in the literature
"Metformin (MTF) and berberine (BBR) share several therapeutic benefits in treating metabolic-related disorders." (abstract, background, passage verified)
pubmedfull study (doi) - supports: Overall and Sex-Specific Effect of Berberine on Glycemic and Insulin-Related Traits: a Sys… (The Journal of nutrition 2023) · cited 13x in the literature
"Berberine lowered fasting glucose (-0.52 mmol/L, 95% CI -0.72 to -0.33; 18 studies, n = 1522), HbA1c (-4.48 mmol/mol, 95% CI -6.53 to -2.44, 7 studies, n = 756)" (abstract, results, passage verified)
pubmedfull study (doi) - supports: The Effect of Berberine Supplementation on Glycemic Control and Inflammatory Biomarkers in… (Clinical therapeutics 2024) · cited 20x in the literature
"BBR supplementation was effective in reducing fasting blood glucose (FBG) (ES WMD : -0.77; 95% CI: -0.90 to -0.63, and ES SMD : -0.65; 95% CI: -0.83 to -0.47), hemoglobin A1C (HbA1C) (ES WMD : -0.57; 95% CI: -0.68 to -0.46)" (abstract, results, passage verified)
pubmedfull study (doi)
Vitamin D deficiency increases susceptibility to developing autoimmune disease.
"So, vitamin D supports those mechanisms. So, vitamin D is really important, and when you don't have enough vitamin D, you're more susceptible to developing autoimmune, which is self-attack." (said at 0:37:42)
Large-scale randomized trial evidence, systematic reviews of observational studies, and Mendelian randomization analyses support the claim that low vitamin D levels increase the risk of autoimmune disease. In the nationwide VITAL randomized controlled trial of 25,871 older adults followed for a median of 5.3 years, vitamin D supplementation (2000 IU/day) reduced the incidence of confirmed autoimmune diseases by 22% compared with placebo (HR 0.78, 95% CI 0.61 to 0.99). Furthermore, meta-analyses consistently show that vitamin D deficiency is associated with a significantly elevated risk of autoimmune conditions such as multiple sclerosis.
Cattle and other ruminants obtain their protein by fermenting fiber into microbes, which serve as the actual protein source for the animal.
"What happens is they're not they're not feeding their body with grass. They're feeding their microbes fiber from the grass. The microbe is protein. That microbe in their gut, they have a huge vat of fermentation. This microbe feeds the the protein to the animal. So these big muscular cows are getting their protein from the microbes." (said at 0:54:30)
The speaker's description accurately reflects the established physiology of ruminant digestion. In cattle and other ruminants, the rumen acts as a large fermentation chamber where symbiotic microorganisms (bacteria, protozoa, and fungi) ferment dietary fiber and carbohydrates, utilizing nitrogen sources to multiply and synthesize microbial crude protein (MCP). When these microbes pass into the abomasum and small intestine, they are digested and absorbed as amino acids, constituting the primary source of metabolizable protein for the animal's maintenance, tissue growth, and milk production.
Human stomach pH is between 1.5 and 3, which matches the acidic stomach pH of carnivores like wolves.
"Your pH in your stomach is between 1.5 and 3, which matches um like a wolf's pH in their stomach that they need to add more meat." (said at 0:55:00)
Human basal gastric pH is typically between 1.5 and 3.5. Systematic comparative analysis of gastric acidity across vertebrate trophic levels shows that humans possess high stomach acidity (pH ~1.5) that is comparable to or more acidic than many carnivores and scavengers, serving primarily as an antimicrobial filter.
Thiazide diuretics cause hypokalemia, and potassium depletion is the mechanism that raises the risk of developing diabetes.
"One thing about that drug is it it does deplete you of potassium. Now you say well okay if you look uh look up low potassium that's called hypokalemia and then look at that in relationship to diabetes you'll see a very high correlated connection. So potassium is a very interesting regulator of the cells that make insulin. So you need enough potassium for it to work. They've also given compared other people they've given other people a blood pressure medication that did not deplete potassium and it didn't lead to diabetes. So in other words um it's really the potassium factor um that um can actually you know throw you into diabetes." (said at 0:58:34)
Published clinical and meta-analytic evidence supports the claim that thiazide diuretic-induced hypokalemia (potassium depletion) is a primary mechanism contributing to thiazide-associated glucose intolerance and new-onset diabetes. In a quantitative meta-analysis of 59 clinical trials comprising 83 thiazide diuretic study arms, decreases in serum potassium were significantly correlated with increases in blood glucose (weighted r = -0.54, p < 0.01). Furthermore, preventing or correcting hypokalemia with potassium supplementation, potassium-sparing diuretics, or renin-angiotensin system inhibitors attenuates or reverses diuretic-induced glucose dysregulation.
- supports: Thiazide diuretics, potassium, and the development of diabetes: a quantitative review. (Hypertension (Dallas, Tex. : 1979) 2006) · cited 454x in the literature
"The Pearson's correlation coefficient, weighted by study sample size, for the relationship between glucose and potassium was -0.54 (95% CI, -0.67 to -0.36; P < 0.01)... These data suggest that thiazide-induced hypokalemia is associated with increased blood glucose. Treatment of thiazide-induced hypokalemia may reverse glucose intolerance and possibly prevent the future development of diabetes." (abstract, results)
pubmedfull study (doi) - supports: New onset diabetes during antihypertensive therapy. (American journal of hypertension 2008) · cited 56x in the literature
"NOD can also sometimes be eliminated by correcting hypokalemia with a potassium-sparing diuretic, and/or potassium supplementation, or by adding a potassium-conserving antihypertensive drug such as an ACEI, ARB, or an anti-aldosterone agent." (abstract, results, passage verified)
pubmedfull study (doi)
Acetic acid in pickle juice activates sensory receptors in the mouth and throat to trigger a reflex in the brain that calms sensory and motor nerve activity.
"if you ever drink the pickle juice, you get this concentrated acetic acid in there. It triggers the sensory nerves. It actually goes into the receptors in your mouth and your throat, goes up to the brain, and your brain's like, "What the heck is this?" And it actually throws the brakes out, and it starts to calm down the nervous system, the sensory nerves and some of the motor nerves. So, that's really how it works. It'll stop that restlessness or irritation of the nerve." (said at 0:30:50)
The host's description reflects the leading scientific hypothesis for how pickle juice rapidly relieves muscle cramps. In human trials of electrically induced muscle cramps, pickle juice reduced cramp duration significantly faster than water (within ~35 to 85 seconds) without altering systemic electrolyte concentrations or plasma volume rapidly enough to explain the effect via metabolic absorption. Researchers demonstrated that this rapid inhibition is consistent with a neurally mediated reflex triggered by acetic acid stimulating sensory receptors in the oropharyngeal/mouth region, which subsequently inhibits alpha motor neuron firing.
Leucine is required to stimulate muscle protein synthesis, while trace minerals are necessary for hair synthesis and growth.
"Specifically um if we're trying to build at least muscle leucine, but if you're trying to build hair you need the trace minerals too." (said at 1:01:25)
The speaker's statement accurately reflects established nutritional and physiological principles. Leucine is well recognized as the primary essential amino acid trigger that activates the mechanistic target of rapamycin (mTOR) pathway to initiate skeletal muscle protein synthesis. Concurrently, essential trace elements (notably zinc, iron, copper, and selenium) serve as vital cofactors for cellular metabolism, enzymatic reactions, and keratinization within hair follicles, and their deficiencies are clinically established causes of impaired hair growth and alopecia.
- supports: Effects of leucine and its metabolite β-hydroxy-β-methylbutyrate on human skeletal muscle … (The Journal of physiology 2013) · cited 488x in the literature
"Of all nutrients, the single amino acid leucine (Leu) possesses the most marked anabolic characteristics in acting as a trigger element for the initiation of protein synthesis." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Minerals and Trace Elements: Key Protectors of Skin Health and Defenders against Skin Diso… (Current medicinal chemistry 2025) · cited 9x in the literature
"The positive role of some minerals (calcium, potassium, sodium, sulfur, and magnesium) and trace elements (iron, zinc, selenium, copper, manganese, and silicon) was found in maintaining skin health. There are also a variety of skin conditions, such as inflammatory disorders (eczema, psoriasis), acne, lichen planus, vitiligo, alopecia areata, or even skin cancer, which require specific approaches for their prevention and treatment considering the saturation of the body and the skin with mineral elements." (abstract, results, passage verified)
pubmedfull study (doi) - supports: The role of protein quality and amino acid composition in preventing sarcopenia and functi… (Frontiers in nutrition 2026) · cited 1x in the literature
"It also highlights the importance of the essential amino acid profile, particularly leucine, which plays a key role in activating anabolic pathways and improves the muscular anabolic response." (abstract, results, passage verified)
pubmedfull study (doi)
Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.